Skip to content

Agile experts focus on achieving your project milestones

Known by delivering quality on time and
matching your research needs

Start a Conversation

Capitalize on the
Ncardia advantage

Our work centers on a simple yet powerful premise:
When we combine deep iPSC knowledge, broad assay capabilities and a demonstrated ability to integrate the biology of human diseases into preclinical research, we can help drug developers make critical decisions earlier and with more confidence.

End-to-End iPSC Solutions

From iPSC generation and differentiation to drug discovery and regenerative medicine services

Find out more

An Experienced Team

Proven and efficient experts focus on quality and timely delivery to help you progress faster

Find out more

A Successful Track Record

Pioneers in iPSC technology and supporting innovations for more
than 15 years

Find out more

 

End-to-End iPSC Solutions

We believe iPSC technology is the solution to enhance clinical success of new therapeutics.

With the Ncardia expertise and capabilities, we can facilitate the applications of iPSC technology at any stage and for multiple purposes. From iPSC generation, at-scale differentiation and cell manufacturing to disease modeling, assay development and screening. 

Whether you seek high-quality cells, relevant screening assays or robust iPSC differentiation processes for cell therapy, Ncardia is your trusted partner.

Contact us

 

       
An Experienced Team

Our team features PhD experts in a diverse range of specialities required to make iPSC successful, including iPSC generation, at-scale differentiation, disease modeling, assay development and high-throughput efficacy and safety screening in multiple therapeutic areas.

That expertise is put to work to develop high-quality cell products, assays and screenings to catalyze the advancement of your therapeutics. 

Team

 

A Successful Track Record

We live iPSC: At Ncardia, we’ve been pursuing and supporting iPSC innovations for more than a decade, collaborating with and/or licensing our iPSC technologies to up-and-coming drug discovery firms, multinational research consortia and large biopharmas.

Our iPSC-based platforms have been successfully leveraged by clients advancing more than 150 research projects for various therapeutic areas.

Find out more

Insightful science advanced through finely tuned project management

Four clear, simple steps. One great way to take your work forward. The “Ncardia Way” begins with listening intently to your goals and then putting a thoughtful, strategic plan into play that’s based on a proven framework for process excellence.

Cross-functional Team

We assemble a cross-functional Ncardia team to work with you to understand your specific needs and set project goals and expectations

Project Plan

Your Ncardia team generates a project plan that identifies clear timelines and milestones matching your needs

Execution

Through frequent communication with your team, we refine the plan and begin execution, ensuring transparency throughout

Move Forward

We deliver on time, and initiate a summary call to share feedback and discuss next steps

How iPSCs Are Transforming
Drug Discovery

iPSC technology has become a powerful tool to bring human biology earlier into the drug discovery and development process.

 

Let's get started

As more and more drug discovery innovators look to capitalize on the unique value only iPSCs can deliver, they look to Ncardia as the uniquely qualified collaborator to join them on their all-important journeys. We’re ready to help make your next step the very best it can be. So let’s start with a conversation – about your vision, goals and expectations for your drug discovery projects.

Marta, QA Officer
Marta, QA officer NCardia